Clinical Trial Update: PK Assessment of Tacrolimus Exposure Before and After a Switch From Twice Daily Immediate-release (Prograf®) to Once-daily Prolonged Release Tacrolimus (Envarsus®) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating tacrolimus exposure before and after switching from twice-daily immediate-release Prograf to once-daily prolonged-relea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Organ Transplantation

Drugs mentioned

• Envarsus (tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Allograft | Phase 4 | Status: COMPLETED